ctx-009
Compass Therapeutics
[]
$cmpx compass therapeutics announces that the phase 2 data of ctx-009 in combination with paclitaxel in patients with biliary tract cancers (btc) will be presented at the asco gi cancers symposium on january 20, 2023 #stocks #news
I am up at 3 a.m. every weekday gathering all premarket runner news for you!   VETERAN WHO SERVED IN IRAQ AND AFGHANISTAN!